Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins-Reference-Cited by-同舟云学术

Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins

Published:2019-10 Issue:5 Volume:5 Page:940-947
ISSN:2095-8099
Container-title:Engineering
language:en
Short-container-title:Engineering

Author:

Li Yan-Hua,Hu Chen-Yu,Wu Nan-Ping,Yao Hang-Ping,Li Lan-Juan

Funder

National Science and Technology

Publisher

Elsevier BV

Subject

General Engineering,Energy Engineering and Power Technology,Materials Science (miscellaneous),General Chemical Engineering,Environmental Engineering,General Computer Science

Reference89 articles.

1. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission;Hui;Lancet Infect Dis,2018

2. Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV;Lee;ACS Chem Biol,2015

3. Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review;Choi;Expert Opin Ther Pat,2017

4. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia;Zaki;N Engl J Med,2012

5. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen;Pallesen;Proc Natl Acad Sci USA,2017

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucosal immunity in upper and lower respiratory tract to MERS-CoV;Frontiers in Immunology;2024-08-30

2. Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir;npj Viruses;2024-06-24

3. Identification of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir;2023-12-04

4. A Multifaceted Computational Approach to Understanding the MERS-CoV Main Protease and Brown Algae Compounds’ Interaction;Marine Drugs;2023-11-30

5. A review on in silico virtual screening methods in COVID-19 using anticancer drugs and other natural/chemical inhibitors;Exploration of Targeted Anti-tumor Therapy;2023-10-26